Presentations offer 5-minute visions for reimaging radiology

Five diverse ideas and reflections on the future of radiology were presented at RSNA 2018 by the winners of the association’s second annual Fast Five competition. The speakers had five minutes to pitch their ideas to their radiology peers at McCormick Place in Chicago on November 29. Creating patient-centric radiology reports Radiology reports, which sum… Read More »

When starting school, younger children are more likely to be diagnosed with ADHD, study says

Could a child’s birthday put him or her at risk for an ADHD misdiagnosis? The answer appears to be yes, at least among children born in August who start school in states where enrollment is cut off at a Sept. 1 birth date, according to a new study led by Harvard Medical School researchers. The… Read More »

Ark launches stomach cancer blood test for early stage stomach cancer detection

Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$ 40 million in Series A funding. Ark’s vision is “a world without late-stage cancer” and its mission is to eliminate late-stage cancer related death by 2048 through the introduction of accurate, affordable, and actionable cancer detection technologies. This record-breaking Series… Read More »

FDA recognizes database as reliable resource for genetic test developers

The Food and Drug Administration is blessing a public database for use by genetic test developers that are submitting premarket submissions. The agency says the database is recognized as a source of valid scientific evidence that now can be used by developers of genetic tests to support clinical validity in premarket submissions to the agency.… Read More »

Sertraline Provides No Benefit for Symptomatic Chronic Breathlessness

December 05, 2018 Share this content: Participants who received sertraline did experience greater improvements in global quality of life scores. Individuals with chronic breathlessness who were treated with 25 to 100 mg sertraline for 4 weeks showed no improvement in symptomatic relief compared with placebo, according to study results published in the European Respiratory Journal.… Read More »